4//SEC Filing
Kennedy Lawrence T. Jr 4
Accession 0001140361-23-000727
CIK 0001439725other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:20 PM ET
Size
10.1 KB
Accession
0001140361-23-000727
Insider Transaction Report
Form 4
BIODESIX INCBDSX
Kennedy Lawrence T. Jr
Director10% Owner
Transactions
- Award
Restricted Stock Units
2023-01-03+91,463→ 91,463 total→ Common Stock (91,463 underlying) - Award
Restricted Stock Units
2023-01-03+27,408→ 27,408 total→ Common Stock (27,408 underlying) - Award
Stock Options (Right to Buy)
2023-01-03+124,998→ 124,998 totalExercise: $2.05Exp: 2033-01-02→ Common Stock (124,998 underlying)
Footnotes (5)
- [F1]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]These RSUs will vest in full on January 3, 2024, generally subject to the Reporting Person's continued service on the Issuer's board of directors (the "Board") through the applicable vesting date, and have no expiration date.
- [F3]These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date, and have no expiration date.
- [F4]Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer.
- [F5]This option vests 40% on January 3, 2025, and the remaining 60% in 36 successive, equal monthly installments measured from January 3, 2025, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date.
Documents
Issuer
BIODESIX INC
CIK 0001439725
Entity typeother
Related Parties
1- filerCIK 0001830773
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 9:20 PM ET
- Size
- 10.1 KB